Date
Title
View
18 Sep 18
Expedeon AG comments on recent share price development (news with additional features)
View
11 Sep 18
Expedeon AG announces commercial-use licence of proprietary technology in diagnostic assay (news with additional features)
View
30 Aug 18
Expedeon AG secures GBP 5 million in debt financing (news with additional features)
View
29 Aug 18
Expedeon AG to present at upcoming investor conferences (news with additional features)
View
09 Aug 18
Expedeon AG (formerly SYGNIS AG) reports financial results for the first six months of 2018 and successful execution of name change (news with additional features)
View
06 Jul 18
SYGNIS AG: SYGNIS AG announces outcome of Annual General Meeting 2018 (news with additional features)
View
30 May 18
SYGNIS AG: SYGNIS AG proposes at AGM change of name to Expedeon AG (news with additional features)
View
11 May 18
SYGNIS AG: SYGNIS AG reports strong financial results for first quarter of 2018 (news with additional features)
View
09 May 18
SYGNIS AG: SYGNIS introduces 2view unique Western blot detection technology (news with additional features)
View
08 May 18
SYGNIS AG: SYGNIS completes acquisition of TGR Biosciences (news with additional features)
View
25 Apr 18
SYGNIS AG: SYGNIS AG reports financial results for fiscal year 2017 - financial guidance achieved (news with additional features)
View
19 Mar 18
SYGNIS AG: SYGNIS AG to raise capital to acquire TGR Biosciences (news with additional features)
View